Derma Sciences Inc (NASDAQ:DSCI), Up By 5.98% ($0.55) From $9.200 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bu
July 3, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, June 18th 2012 stating that Derma Sciences Inc (NASDAQ:DSCI) was expected to go Up due to the Bullish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=dsci&id=285465
At the time this story was written, Derma Sciences Inc (NASDAQ:DSCI) is Up By $0.55 (5.98%) since the BUYINS.NET report was released.
The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.
The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php
Derma Sciences Inc (NASDAQ:DSCI) - Derma Sciences, Inc. engages in manufacturing, marketing, and selling wound care, wound closure and specialty securement devices, and skin care products. The company offers advanced/active wound care products comprising Medihoney dressings to manage non-chronic and hard-to-heal wounds, such as chronic ulcers, burns, and post-operative wounds; Bioguard dressings for prophylactic use to prevent hospital or community acquired infections through wound sites; Algicell Ag, an antimicrobial dressing; Xtrasorb dressings that convert fluid within the dressing to a gel and locks the exudates into the dressing; TCC-EZ, a dressing system for the management of diabetic foot ulcers; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and Dermagran products. It also provides traditional wound care products, such as gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices, as well as adhesive bandages and related first aid products for the medical, industrial, private label, and retail markets. In addition, the company offers wound closure strips, nasal tube fasteners, and catheter fasteners to doctors, clinics, nursing homes, hospitals, and other institutions; and barrier creams and ointments, antibacterial cleansing foams and sprays, shampoos and body washes, hand sanitizers, bath additives, body oils, and moisturizers to nursing homes, hospitals, and home healthcare agencies. Further, it involves in developing DSC127, an angiotensin analog for use in wound healing and scar reduction. The company serves wound care centers, long-term care facilities, hospitals, home healthcare agencies, physicians offices, and closed door pharmacies. It sells its products primarily through independent distributors in the United States, Canada, and internationally. The company was founded in 1984 and is headquartered in Princeton, New Jersey.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net